Important information regarding cookies and
By using this website, you consent to the use of cookies in accordance with the IMB Cookie Policy. For more information on cookies, see our Cookie Policy.
Full Version | Search

The Irish Medicines Board -

IMB Logo

Drug Safety Newsletter 47th Edition

19 April 2012

Topics covered in this edition of the newsletter include:

  • Aliskiren - New contraindications and warnings due to risks of cardiovascular and renal adverse reactions (brands include, Rasilez, Rasilez HCT, Rasilamlo) 
  • Proton pump inhibitors - Small increased risk of bone fractures with long term use in patients with risk factors
  • Oral Methotrexate - Risk of unintentional overdose due to medication errors
  • Miconazole oral gel (Daktarin oral gel) - Interaction with warfarin
  • Children's liquid paracetamol medicines - New dosage instructions

Drug Safety Newsletter 47th Edition

Date Printed: 19 April 2014

© Irish Medicines Board 2014 | Developed by Engine Solutions

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971